Federal Register / Vol. 65, No. 27 / Wednesday, February 9, 2000 / Notices 6395

Clearance Officer, National Place, Suite

1220, 1331 Pennsylvania Avenue, NW,

Washington, DC 20530.

Overview of this information

collection:

(1) Type of Information Collection:

New collection.

(2) Title of the Form/Collection: COPS

Problem-Solving Management Survey.

(3) Agency form number, if any, and

the applicable component of the

Department of Justice sponsoring the

collection: Form: COPS PPSE/01. Office

of Community Oriented Policing

Services, U.S. Department of Justice.

(4) Affected public who will be asked

or required to respond, as well as a brief

abstract: Captains, Chiefs, Detectives/

Sergeants, and Crime Analysts from 75

large police agencies that have received

COPS 1999 School Based Partnership

Grants will be asked to respond

(approximately 300). The ProblemSolving Management Survey will collect

basic information about the capacity of

police agencies to prioritize problems,

their knowledge of agency resources,

and their understanding of problemsolving information as it relates to

problem-oriented policing.

The COPS office will use the

information collected to identify the

information necessary for police

executives to effectively utilize

resources as it relates to problemsolving and to examine existing

problem-oriented policing tracking

systems for the purpose of identifying

best practices in problem-solving

management. Data from the surveys will

be used to produce a final ProblemSolving Knowledge Management Model.

A brochure and video of the ProblemSolving Knowledge Model will assist

agencies in problem prioritization, and

the allocation of resources in support of

problem-oriented policing.

(5) An estimate of the total number of

respondents and the amount of time

estimated for an average respondent to

respond: Surveys will be administered

by telephone to approximately 300

position-specific law enforcement

officials within 75 large police agencies

who have been awarded COPS 1999

School Based Partnership Grants. The

four specific positions that will be

questioned in each agency are Captains,

Chiefs, Detectives or Sergeants, and

Crime Analysts. Administrative

preparation and survey completion will

take approximately 0.75 hours per

respondent (there is no record burden

for this collection).

(6) An estimate of the total public

burden (in hours) associated with the

collection: Approximately 225 hours.

If additional information is required

contact: Ms. Brenda E. Dyer, Deputy

Clearance Officer, United States

Department of Justice, Information

Management and Security Staff, Justice

Management Division, National Place,

Suite 1220, 1331 Pennsylvania Avenue,

NW, Washington, DC 20530.

Dated: February 3, 2000.

Brenda E. Dyer,

Department Deputy Clearance Officer, United

States Department of Justice.

[FR Doc. 00–2898 Filed 2–8–00; 8:45 am]

BILLING CODE 4410–AT–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration;

By Notice dated August 17, 1999, and

published in the Federal Register on

August 27, 1999, (64 FR 46953), B.I.

Chemicals, Inc., 2820 N. Normandy

Drive, Petersburg, Virginia 23805, made

application by renewal to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

the basis classes of controlled

substances listed below:

Drug Schedule

Amphetamine (1100) .................... II

Methadone (9250) ........................ II

Levo-alphacetylmethadol (9648) .. II

The firms plans to bulk manufacture

the listed controlled substances for

formulation into finished

pharmaceuticals.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of B.I. Chemicals, Inc. to

manufacture the listed controlled

substances is consistent with the public

interest at this time. DEA has

investigated the firm on a regular basis

to ensure that the company’s continued

registration is consistent with the public

interest. These investigations have

included inspection and testing of the

company’s physical security systems,

audits of the company’s records,

verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to 21 U.S.C. 823 and 28 CFR

0.100 and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: December 30, 1999.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–2873 Filed 2–8–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances;

Notice of Registration

By Notice dated October 8, 1999, and

published in the Federal Register on

October 18, 1999, (64 FR 56226), Glaxo

Wellcome, Inc., Attn: Jeffrey A. Weiss,

1011 North Arendell Avenue, PO Box

1217, Zebulon, North Carolina 27597–

2309, made application to the Drug

Enforcement Administration to be

registered as an importer of

Remifentanil (9739), a basic class of

controlled substance listed in Schedule

II.

The remifentanil is being imported for

the production of Ultiva dosage forms

and for research and new product

development.

No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

Section 823(a) and 952(a), and

determined that the registration of Glaxo

Wellcome, Inc. to import remifantanil is

consistent with the public interest and

with United States obligations under

international treaties, conventions, or

protocols in effect on May 1, 1971, at

this time. DEA has investigated the firm

on a regular basis to ensure that the

company’s continued registration is

consistent with the public interest.

These investigations have included

inspection and testing of the company’s

physical security systems, audits of the

company’s records, verification of the

company’s compliance with state and

local laws, and a review of the

company’s background and history.

Therefore, pursuant to section 1008(a) of

the Controlled Substances Import and

Export Act and in accordance with Title

21, Code of Federal Regulations,

§ 1301.34, the above firm is granted

registration as an importer of the basic

class of controlled substance listed

above.

Dated: January 4, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–2874 Filed 2–8–00; 8:45 am]

BILLING CODE 4410–09–M